CLINICAL_TRIALS
ClinicalTrials.gov record update
Study to Evaluate the Safety, Reactogenicity & Immunogenicity of a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™, vs Hib-MenC or Priorix™ Only, in Toddlers (13-14 m) Primed With 3 Doses of Hib (as Part of a DTPa -Containing Vaccine) & MenC-CRM197 Conjugate Vaccines.
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00263653
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:36:25.878227+00:00
- Published At
- 2016-09-21T00:00:00+00:00
- Record Updated At
- 2016-09-21
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Haemophilus Influenzae Type b", "Neisseria Meningitidis"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2016-09-21"- protocolSection.identificationModule.nctId
"NCT00263653"- protocolSection.identificationModule.officialTitle
"Study to Evaluate the Safety, Reactogenicity \u0026 Immunogenicity of a Booster Dose of GSK Biologicals\u0027 Hib-MenC Given With Priorix\u2122, vs Hib-MenC or Priorix\u2122 Only, in Toddlers (13-14 m) Primed With 3 Doses of Hib (as Part of a DTPa -Containing Vaccine) \u0026 MenC-CRM197 Conjugate Vaccines."- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.